JPRN-UMIN000017279招募中未知
Effect of denosumab for the treatment of postmenoposal osteoporosis in woman caused by the loss of ovarian function due to gynecologic malignancies - Effect of denosumab for the treatment of osteoporosis in women with gynecologic malignancies
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Patients are excluded if being 1. with concomitant use of other agents for osteoporosis 2. with concomitant use of other agents, which potentially affect bone turnover 3. with hypersensitivity to denosumab or other bisphosphonates 4. with hypocalcaemia 5. with severe nephropathy 6. with advanced or metastatic malignancy 7. inappropriate to participate in the study
研究者
相似试验
已完成
不适用
The effect of denosumab for the treatment of osteoporosis in hemodialysis patientsOsteoporosisJPRN-UMIN000014458Saiseikai Kumamoto Hospital40
已完成
3 期
A Study to Evaluate Denosumab in the Treatment of Postmenopausal OsteoporosisOsteoporosisNCT00089791Amgen7,808
已完成
不适用
The prospective study of denosumab for the treatment of osteoporosis in hemodialysis patientsOsteoporosisJPRN-UMIN000022179Yujinkai Medical Corporation Yujin-yamazaki Hospital38
已完成
不适用
The efficacy of re-challenge of denosumab in postmenopausal women with hormone receptor-positive breast cancer who are currently on or will iniate an aromatase inhibitor in the adjuvant settingbreast cancerJPRN-UMIN000030328Kyoto Prefectural University of medicine10
已完成
2 期
The efficacy of the use of denosumab in the prevention of aromatase inhibitor-induced bone loss in postmenopausal women with hormone receptor-positive breast cancer who are currently on or will iniate an aromatase inhibitor in the adjuvant settingBreast CancerJPRN-UMIN000013863Department of Endocrine and breast cancer, Kyoto Prefectural University of medicine100